UCL News


'Cough medicine may be the unexpected treatment Parkinson's patients need'

20 February 2023

A team of UCL researchers, led by Professor Anthony Schapira (UCL Queen Square Institute of Neurology) are expected to launch a phase 3 clinical trial with the active ingredient of cough remedies, ambroxol, to assess its ­effectiveness in hundreds of people with Parkinson’s.

Read: Mirror